A Murine Orthotopic Allograft to Model Prostate Cancer Growth and Metastasis
Overview
Affiliations
Prostate cancer is one of the most common cancers in men in the United States. Comprehensive understanding of the biology contributing to prostate cancer will have important clinical implications. Animal models have greatly impacted our knowledge of disease and will continue to be a valuable resource for future studies. Herein, we describe a detailed protocol for the orthotopic engraftment of a murine prostate cancer cell line (Myc-CaP) into the anterior prostate of an immune competent mouse.
Orthotopic and metastatic tumour models in preclinical cancer research.
Stribbling S, Beach C, Ryan A Pharmacol Ther. 2024; 257:108631.
PMID: 38467308 PMC: 11781865. DOI: 10.1016/j.pharmthera.2024.108631.
Chou C, Tseng C, Lin Y, Wang M, Chen P, Chang D Cancer Gene Ther. 2023; 31(2):250-258.
PMID: 38072969 PMC: 10874888. DOI: 10.1038/s41417-023-00699-8.
Modeling Human Prostate Cancer Metastasis in Mice Resection of Subcutaneous Allografts.
Peiffer L, Hicks J, Sosa R, De Marzo A, Sfanos K, Maynard J Front Oncol. 2022; 12:877536.
PMID: 35574356 PMC: 9093182. DOI: 10.3389/fonc.2022.877536.
Loss of Myeloid BMPR1a Alters Differentiation and Reduces Mouse Prostate Cancer Growth.
Ihle C, Straign D, Provera M, Novitskiy S, Owens P Front Oncol. 2020; 10:357.
PMID: 32318332 PMC: 7154049. DOI: 10.3389/fonc.2020.00357.
Development of Zinc-Specific iCEST MRI as an Imaging Biomarker for Prostate Cancer.
Yuan Y, Wei Z, Chu C, Zhang J, Song X, Walczak P Angew Chem Int Ed Engl. 2019; 58(43):15512-15517.
PMID: 31430007 PMC: 7261412. DOI: 10.1002/anie.201909429.